NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
19/05/2026
Voltar para busca
Dado oficial do USPTO
LUMIRADX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
67
Atualização mais recente
19/05/2026
Tipo de marca
Verbal
Classes Nice
10, 44
Data de depósito
14/07/2016
Data de registro
27/10/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/04/2026
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
25
Localização do titular
Rotkreuz, CH
Examinador
EVANKO, PATRICIA MALESARDI
Localização atual
Historical data usage
Titulares e representantes
Titulares
Roche Diagnostics International AG
LUMIRADX INTERNATIONAL LTD
Representantes
Mona Gupta Roche Diagnostics Operations, Inc.
Classificação técnica
Classes Nice
Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Diagnosticexamination and monitoring equipment for medical purposesapparatus for the detection of infectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse ; medical diagnostic apparatus for the detection of chronic diseasesinfectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse ; medical diagnostic instruments for detecting chronic diseasesinfectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse ; diagnostic instruments for medical use for the testing and analysis of assays; electronic apparatus for medical purposes for the monitoring of glucose levelsweighttemperatureposturesleepstress levelsblood pressureinternational normalized ratiovital signs and detection of chronic diseasesinfectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse; analytical instruments for medical usenamely device for monitoring glucose levelsweighttemperatureposturesleepstress levelsblood pressureinternational normalized ratiovital signs and detection of chronic diseasesinfectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse ; apparatus for carrying-out diagnostic tests for medical purposesnamely measurement and detection of glucose levelsweighttemperatureposturesleepstress levelsblood pressureinternational normalized ratiovital signs and detection of chronic diseasesinfectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse ; apparatus for use in medical analysismedical diagnostic instruments for the analysis of glucose levelsweighttemperatureposturesleepstress levelsblood pressureinternational normalized ratiovital signs and detection of chronic diseasesinfectious diseasescardiovascular diseases and conditionsdiabetescancerwomen's health including pregnancysexually transmitted diseaseshematology and drugs of abuse; diagnostic measuring apparatus for medical usenamely device for monitoring glucose levelsweighttemperatureposturesleepstress levelsblood pressureinternational normalized ratiovital signsblood counts and blood analysis ; apparatus for blood analysis for medical purposes; medical instruments for drug abuse testing; medical apparatus for detecting drugs of abuse; medical apparatus for detecting and measuring the level of substances in bodily fluids; and parts and fittings for all the aforesaid goodsincluded in the class
Classe 44
Healthcare services; medical diagnostic testing and reporting services; providing medical information and advisory services; consulting services in the field of health; medical consulting regarding medical diagnostic apparatus and instruments; advice relating to the medical needs of elderly people; providing medical advisory services relating to medical instruments; providing medical advisory services relating to medical services; medical reporting servicescompilation of medical reports; medical analysis servicesproviding medical record analysis and assessment services designed to provide patients and healthcare professionals with customized diagnostic informationpatient diagnosesmedical treatment plans and healthcare management plans; medical health assessment services; medical screening; medical services for the diagnosis of conditions of the human body; medical testing for diagnostic purposes; surgical diagnostic services; health and medical services delivered via online interactive database enabling medical device users to exchange information with healthcare providers; adviceconsultancy and information on the aforesaidincluded in the class; online health and medical servicesproviding an interactive database for exchanging health and medical information between a medical device user and healthcare providersdelivered via a global computer network
Publicações
Histórico de despachos e eventos da marca no USPTO.
67 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
24/04/2026
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24/04/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
24/04/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
24/04/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
24/04/2026
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
30/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/03/2026
E815
TEAS SECTION 8 & 15 RECEIVED
06/01/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/09/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/09/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
16/08/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
27/10/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
23/09/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/09/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/03/2020
EX5G
SOU EXTENSION 5 GRANTED
17/03/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/03/2020
EXT5
SOU EXTENSION 5 FILED
09/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/09/2019
EX4G
SOU EXTENSION 4 GRANTED
11/09/2019
EXT4
SOU EXTENSION 4 FILED
11/09/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/09/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/03/2019
EX3G
SOU EXTENSION 3 GRANTED
11/03/2019
EXT3
SOU EXTENSION 3 FILED
11/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/08/2018
EX2G
SOU EXTENSION 2 GRANTED
09/08/2018
EXT2
SOU EXTENSION 2 FILED
09/08/2018
EEXT
SOU TEAS EXTENSION RECEIVED
09/08/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/03/2018
EX1G
SOU EXTENSION 1 GRANTED
02/03/2018
EXT1
SOU EXTENSION 1 FILED
02/03/2018
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/07/2017
PUBO
PUBLISHED FOR OPPOSITION
18/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/06/2017
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
14/06/2017
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/05/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/03/2017
GNRT
NON-FINAL ACTION E-MAILED
31/03/2017
CNRT
NON-FINAL ACTION WRITTEN
31/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/03/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/03/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/10/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/10/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/10/2016
GNRT
NON-FINAL ACTION E-MAILED
12/10/2016
CNRT
NON-FINAL ACTION WRITTEN
12/10/2016
DOCK
ASSIGNED TO EXAMINER
06/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/07/2016
NWAP
NEW APPLICATION ENTERED
18/07/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LUMIRADX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.